China Health Group Cancels 40.6 Million Share Options, Keeps Future Grant Capacity Intact

China Health Group ( (HK:0673) ) has provided an announcement.

China Health Group Limited has cancelled in full the 40,638,000 share options it granted on 2 February 2026 to 11 grantees, exercising the board’s discretion under its share option scheme after none of the options had been validly exercised. The cancellation means these options are still counted as utilised for the purpose of the scheme’s overall and service provider mandate limits, leaving 7,261,476 shares and 4,789,947 shares, respectively, available for future grants, which could influence how the group structures future equity incentives and capital management.

The board’s move effectively closes this particular round of incentive awards while preserving the remaining capacity under the scheme for potential reallocation in line with future strategic or human capital needs. For shareholders and other stakeholders, the decision signals an adjustment in the company’s approach to option-based remuneration without an immediate dilutive impact from the cancelled grant, although the reserved capacity may still be deployed in subsequent grants.

The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.58 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.

More about China Health Group

China Health Group Limited, incorporated in Bermuda and carrying on business in Hong Kong as CHG HS Limited, is listed on the Hong Kong Stock Exchange under stock code 673. The company operates through a group structure and is overseen by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical Hong Kong-listed corporate governance framework.

Average Trading Volume: 444,610

Technical Sentiment Signal: Hold

Current Market Cap: HK$803.5M

For an in-depth examination of 0673 stock, go to TipRanks’ Overview page.